The best indicator for ARK Genomic (ARKG)
We backtested 20 indicators across daily, weekly and hourly charts on real ARK Genomic (ARKG) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for ARK Genomic (ARKG) over ~11.6 years — beating buy-and-hold by 15.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 20.1% | 0.83 | -47.1% | 74.7% | 79 | 15.0% |
| 2 | CCI ✓ | Daily | 15.6% | 0.69 | -38.2% | 77.0% | 61 | 10.4% |
| 3 | Williams %R ✓ | Daily | 14.1% | 0.63 | -53.3% | 69.7% | 89 | 8.9% |
| 4 | Stochastic ✓ | Weekly | 6.4% | 0.38 | -62.1% | 71.4% | 14 | 1.2% |
| 5 | WaveTrend (8/6/4) ✓ | Daily | 6.1% | 0.35 | -67.5% | 59.2% | 49 | 0.9% |
| 6 | RSI Mean-Reversion ✓ | Daily | 4.1% | 0.31 | -49.4% | 75.0% | 16 | -1.1% |
| 7 | Holy Grail Confluence ✓ | Daily | 3.0% | 0.24 | -66.2% | 81.2% | 16 | -2.2% |
| 8 | Bollinger Mean-Reversion ✓ | Daily | 2.1% | 0.2 | -35.6% | 68.2% | 44 | -3.1% |
| 9 | Rate of Change ✓ | Daily | 1.7% | 0.2 | -68.2% | 41.3% | 179 | -3.5% |
| 10 | SMA 50/200 Cross | Daily | 4.4% | 0.3 | -61.2% | 30.0% | 10 | -0.7% |
| 11 | Bollinger Mean-Reversion ✓ | Weekly | 4.4% | 0.3 | -62.1% | 60.0% | 10 | -0.7% |
| 12 | EMA 50/200 Cross | Daily | 5.2% | 0.32 | -62.2% | 33.3% | 9 | -0.0% |
| 13 | Rate of Change | Weekly | 1.3% | 0.18 | -61.9% | 27.9% | 43 | -3.8% |
| 14 | Williams %R ✓ | Weekly | 1.0% | 0.16 | -62.1% | 68.8% | 16 | -4.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For ARK Genomic (ARKG), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More etf
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.